About

Products

Services

Applications

Knowledge

About

Products

All Products
Complement Assays
Cell-Based Assays
Gene Therapy Assays
CCP Assays

Services

CRO Services
Diagnostic Services
Custom Cell Development
Cell Manufacturing

Applications

Knowledge

Scientific Resources
Product Documentation

Svar offers a unique combination of scientific expertise, high-quality assay products, strong services, and proprietary technology platforms that provide a flexible and seamless experience for different customer needs.

About Svar

Life science is always asking new questions. It's essential to the discovery process.

Career

We are always interested in finding new talented individuals to join our team, from new graduates to experienced professionals.

Work with Us

Distributors

We collaborate with our valued distributors to provide our technology to end customers worldwide, leveraging our distributors' local knowledge and expertise

Our Distributors

Events

Join us at leading life science events worldwide. Explore our Event Calendar for a full-year view of major conferences and scientific gatherings.

Meet Us at an Event

Complement Excellence Award

The Svar Complement Excellence Award recognizes outstanding contributions to the complement field by scientists and physicians worldwide. Find out more about how to apply and previous winners.

Complement Excellence Award

News

Stay up to date with the latest developments, announcements, and expert perspectives.

View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring

All Products

Our products are trusted worldwide in research, clinical, and commercial laboratory settings.

Our Products

Complement Assays

Functional and biomarker assays for the exploration of every angle of the complement system

Complement Products

Cell-Based Assays

Our cell-based bioassays are based on iLite^® technology – a cleverly designed cell-based assay system with reporter gene readouts

Gene Therapy Assays

AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity

CCP Assays

Solutions for detecting and semi-quantitating IgG antibodies against CCP

CCP Assays

We offer high-quality flexible services in many areas within life science. Our CRO Services offer extensive bioanalytical, biomarker discovery, and QC testing services in a GMP setting.

In addition, we offer expert diagnostic services for autoimmune and neurological disorders, as well as cell and manufacturing services.

CRO Services

Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.

Diagnostic Services

With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.

Custom Cell Development

Let us develop a custom iLite^® cell line tailored to your needs.

iLite^® Custom Cell Lines

Cell Manufacturing

Our cell services are highly reliable and innovative, tailored to your manufacturing needs

Our solutions for drug development, diagnostics, and regulatory compliance – covering everything from therapeutic applications and biomarker testing to bioanalysis and quality assurance

Potency Testing

Explore how our expertise in potency testing, functional characterization, and immunogenicity assessment can support your drug development journey from discovery through regulatory submission

Potency Testing

Safety Assessment

Ensure therapeutic safety with our immunogenicity assays, hemocompatibility panels, and complement pathway testing designed to meet global regulatory standards.

Safety Assessment

Biomarker Profiling

From multiplex ELISA to custom biomarker assay development, we help you generate actionable insights for precision medicine.

Biomarker Profiling

Clinical Assessment

Our CE-marked diagnostic kits and specialized services enable accurate disease detection and patient stratification for personalized treatment strategies.

Clinical Assessment

Bioanalysis

Our GLP-compliant bioanalytical services provide accurate PK, TK, and PD data through optimized workflows and sensitive biomarker assays for regulatory success.

Bioanalysis (PK/TK/PD) – GLP Compliant

Regulatory Testing

Achieve full regulatory compliance with our GMP-qualified QC testing for biologics and biosimilars, ISO 15189-accredited diagnostic services, and customized cell-based solutions.

Regulated Testing

Complement System Evaluation

Access a complete portfolio of complement ELISAs, biomarker panels, and functional assays to evaluate complement pathways and support safety and efficacy studies.

Complement System Evaluation

Gene & Cell Therapy Evaluation

Accelerate advanced therapy development with our custom potency assays, AAV-specific safety platforms, and mechanism-of-action reflective cell-based solutions backed by GMP expertise.

Gene & Cell Therapy Evaluation

Biosimilar & Biobetter Assessment

Demonstrate comparability and functional performance with our side-by-side assay panels, Fc-effector function testing, and iLite® bioassays tailored for biosimilars and biobetters.

Biosimilar & Biobetter Assessment

Valuable resources, webinars, downloads, and more. Get the latest white papers, safety data sheets, and instruction manuals

Scientific Resources

Explore our collection of white papers, technical notes, posters, webinars, and our list of peer-reviewed publications highlighting how our technologies are used across diverse applications.

Product Documentation

Instruction manuals, safety data sheets, certificates, and more for Svar's products.

Product Documentation

BM5028 iLite® CD20 (+) Svar Luc Assay Ready Cells
BM5001 iLite® ADCC Effector FcγRIIIa (V)
BM5004 iLite® ADCP Effector FcγRIIa
BM4073 iLite® C3a Assay Ready Cells
BM4075 iLite® C5a Assay Ready Cells
BM4052 iLite® RANKL Assay Ready Cells
BM4044 iLite® TNF-alpha Xcel Assay Ready Cells
BM4049 iLite® Type I IFN FAST Assay Ready Cells
BM3071 iLite® FGF-21 Assay Ready Cells
BM4055 iLite® G-CSF Assay Ready Cells
BM4050 iLite® GM-CSF Assay Ready Cells
BM4021 iLite® VEGF Assay Ready Cells
BM4080 iLite® hCG Assay Ready Cells
BM3060 iLite® Insulin Assay Ready Cells
BM4023 iLite® IL-23 Assay Ready Cells
BM4012 iLite® IL-12 Assay Ready Cells
BM4002 iLite® IL-2 Assay Ready Cells
BM4061 iLite® IL-6 Assay Ready Cells
BM4025 iLite® TLR4 Assay Ready Cells
BM6069 iLite® TLR9 Assay Ready Cells
BM6100 iLite® AAV Responsive Reporter Assay Ready Cells
BM6002 iLite® AAV2 Packaging Assay Ready Cells
BM6005 iLite® AAV5 Packaging Assay Ready Cells
BM6006 iLite® AAV6 Packaging Assay Ready Cells
BM6008 iLite® AAV8 Packaging Assay Ready Cells
BM6009 iLite® AAV9 Packaging Assay Ready Cells
BM5005 iLite® CD3 Effector
BM5025 iLite® CD19 (+) Target
BM5026 iLite® CD19 (-) Target
BM5010 iLite® CD20 (+) Target
BM5015 iLite® CD20 (-) Target
BM5035 iLite® EGFR (+) Target
BM5036 iLite® EGFR (-) Target
BM5011 iLite® HER2 (+) Target
BM5016 iLite® HER2 (-) Target
BM5013 iLite® mTNF-alpha (+) Target
BM5014 iLite® mTNF-alpha (-) Target
BM5017 iLite® mVEGF (+) Target
BM5018 iLite® mVEGF (-) Target
AAV9COMPLRUO AAV9-induced Complement Activation ELISA
COMPL C4d RUO Complement C4d
COMPL FPQ RUO Complement Factor P Quantitative Assay
COMPL TCC RUO Complement TCC
COMPL FPF RUO Complement Factor P Functional Assay
COMPLAP330 WIESLAB® Complement Alternative Pathway (IVD)
COMPLAP330RUO WIESLAB® Complement Alternative Pathway (RUO)
COMPLCP310 WIESLAB® Complement Classical Pathway (IVD)
COMPLCP310RUO WIESLAB® Complement Classical Pathway (RUO)
COMPLMP320 WIESLAB® Complement MBL Pathway (IVD)
COMPLMP320RUO WIESLAB® Complement MBL Pathway (RUO)
COMPL300 WIESLAB® Complement Screen (IVD)
COMPL300RUO WIESLAB® Complement Screen (RUO)
RA-96 PLUS IMMUNOSCAN CCPlus® (IVD)
RA-96 PLUS RUO IMMUNOSCAN CCPlus® (RUO)
008 C-/P-ANCA
017 Cardiolipin Antibodies (IgA)
018 Autoimmune Liver Disease Screen
020 ANA (HEp-2)
023 dsDNA Antibodies (IgG)
024 ANA Specificities
025 Sm Antibodies
027 SSA/Ro60 Antibodies
028 SSB/La Antibodies
031 Ribosomal P-Protein (Ribo-P) Antibodies
032 SSA/Ro52 Antibodies
047 FGFR3 Antibodies (IgG)
071 Endomysial Antibodies (IgA)
074 Transglutaminase Antibodies (IgA)
079 Acetylcholine Receptor Antibodies
082 Smooth Muscle Antibodies (SMA)
084 Mitochondrial Antibodies (AMA)
086 Adrenal Cortex Antibodies
087 Parietal Cell Antibodies
089 GAD Antibodies
090 Islet Cell Antibodies
093 MAG Antibodies
095 HSP-70 Antibodies
098 Histone Antibodies
100 GBM Antibodies (IgG4)
110 Insulin Antibodies
111 IA-2 Antibodies
113 ZnT8 Antibodies
117 mGluR1 Antibodies (IgG)
118 mGluR5 Antibodies (IgG)
119 Neurofilament Heavy Chain (pNfH)
140 THSD7A Antibodies (IgG)
141 cN-1A (Mup44) Antibodies (IgG)
146 Beta-2-Glycoprotein Antibodies (IgA)
205 Envoplakin Antibodies (IgG)
220 Hu (ANNA-1) Antibodies (IgG)
240 Streptolysin O Antibodies
247 PLA2R Antibodies ELISA (IgG)
280 Collagen Type VII IgG Antibodies (IgG)
291 HLA-DQB1*06:02 (Narcolepsy)
355 Sulfatide Antibodies (IgM)
450 RNA Polymerase Antibodies
485 HMGCR Antibodies
500 Glomerulonephritis – Extended Analysis
501 ANCA Vasculitis/Anti-GBM Disease (Goodpasture Syndrome)
510 Antiphospholipid Syndrome (APS)
511 Systemic Lupus Erythematosus (SLE)/Sjogren's Syndrome
515 Autoimmune Liver Disease
516 Cardiolipin Antibodies (IgG, IgM)
517 Beta-2-Glycoprotein 1 Antibodies (IgG, IgM)
522 Systemic Sclerosis/Scleroderma
527 Systemic Sclerosis/Scleroderma – Extended Analysis
530 Sudden Deafness
531 Diabetes Mellitus Type 1
534 Guillain-Barré Syndrome/AIDP
620 Autoimmune Nodopathy/CIDP – Screen IgG
533 Autoimmune Nodopathy/CIDP – Extended Analysis with Reflex (IgG1-4)
541 Drug Induced Lupus
543 Myasthenia Gravis
548 Myositis/ Interstitial Lung Disease (ILD) Screen
550 Bullous Dermatosis
555 Inflammatory Myopathies (Myositis)/Interstitial Lung Disease (ILD)
563 Lambert Eatons Myastena Syndrome (LEMS)
566 CNS Tissue Damage Biomarker
568 Stiff Person Syndrome
569 Paraneoplastic Retinopathy Syndrome (MAR/CAR)
571 Hereditary Angioedema (HAE)
572 Complement Deficiency
584 Primary Membranous Nephropathy (PMN)
575 Autoimmune Pancreatitis Type 2 (AIP2)
600 Fibrillarin Antibodies
546 Ganglioside Antibodies (IgG, IgM)
710 PM/Scl (100kD) Antibodies
720 Th/To Antibodies
730 Amphiphysin Antibodies (IgG)
736 Recoverin Antibodies (IgG)
737 SOX1 Antibodies (IgG)
740 Yo (Purkinje cell) Antibodies (IgG)
742 Zic4 Antibodies (IgG)
750 Ri (Nova 1/ ANNA-2) Antibodies (IgG)
760 Tr Antibodies (IgG)
761 PCA-2 Antibodies
772 AMPA Receptor 1/2 Antibodies (IgG)
780 21-Hydroxylase Antibodies
790 Ma (Ma-2/Ta) Antibodies (IgG)
831 VGKC Antibodies (IgG)
833 LGI-1 Antibodies (IgG)
835 CASPR2 Antibodies (IgG)
837 Alpha-Enolase Antibodies
838 Glycine Receptor Antibodies (IgG)
839 Ryanodin Receptor 1 (RyR1) Antibodies
845 VGCC Antibodies
850 Carbonic Anhydrase II Antibodies
851 DPPX Antibodies (IgG)
852 IgLON5 Antibodies (IgG)
854 CARP VIII Antibodies (IgG)
855 HOMER3 Antibodies (IgG)
856 ITPR1 Antibodies (IgG)
859 Lactoferrin (DNA-Bound) Antibodies (IgG)
870 CV2/CRMP5 Antibodies (IgG)
874 ANNA-3 Antibodies
875 NMDA Receptor Antibodies (IgG)
877 GABA B Receptor Antibodies (IgG)
880 Aquaporin 4 (AQP4) Antibodies (IgG)
884 MOG Antibodies (IgG)
890 C1q Antibodies
920 C1q
925 C1 INH Level
930 C3d
958 Lrp4 Antibodies
959 Ganglionic AChR Antibodies
960 MuSK Antibodies (IgG)
965 Titin Antibodies (IgG)
970 Trib2 Antibodies
988 CXCL13
989 Orexin (Hypokretin-1)
990 Tau
991 pTau
992 Beta-Amyloid 42
994 Neurofilament Light (NfL)
260, 282 Bullous Pemphigoid (BP180/BP230) Antibodies (IgG)
403 Phosphatidylserine Antibodies (IgGAM)
404 Phosphatidylserine Antibodies (IgA)
405 Phosphatidylserine Antibodies (IgG)
406 Phosphatidylserine Antibodies (IgM)
460, 470 Desmoglein 1 and 3 Antibodies (IgG)
900 C3
910 C4
565 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD
549 Neuromyelitis Optica Spectrum Disorder – Tissue Damage Biomarkers
536 BPI-ANCA (IgG, IgA)
573 Complement Function
931 Properdin
520 Systemic Inflammatory Disease
567 Alzheimer's Disease Biomarkers
579 Antiphospholipid Syndrome (APS) – Extended Analysis
570 Complement Activation
997 Beta Amyloid Ratio 42/40
926 C1 INH Function
996 GFAp Antibodies (IgG)
581 Multiple Sclerosis (MS)
580 Amyotrophic Lateral Sclerosis (ALS) Biomarkers
585 Autoimmune Epilepsy
586 Autoimmune Epilepsy – Extended Analysis
872 Neurexin-3 Alpha Antibodies (IgG)
876 GABA A Receptor Antibodies (IgG)
080 Agrin Antibodies
052 Dopamin-2 Receptor Antibodies (IgG)
871 Neurochondrin Antibodies (IgG)
804 TS-HDS Antibodies (IgM)
986 Neurogranin
535 Small Fiber Neuropathy (SFN)
195 Autoimmune Encephalitis
199 Paraneoplastic Syndrome (IIF and Immunoblot)
560 Autoimmune Encephalitis, Paraneoplastic Syndrome & Cerebellar Ataxia
562 Neuronal Antibodies – Extended Analysis
587 Pediatric Autoimmune Encephalitis
574 Ophelia’s Syndrome (Paraneoplastic Cerebellar Ataxia or Limbic Encephalitis)
588 Pediatric Autoimmune Encephalitis – Extended Analysis
987 pTau-181
805 Plexin D1 Antibodies (IgG)
539 Small Fiber Neuropathy (SFN) – Extended Analysis
878 Sez6L2 Antibodies (IgG)
011 PR3-ANCA (IgG)
015 MPO-ANCA (IgG)
002 GBM Antibodies (IgG)
245 PLA2R Antibodies IIF (IgG)
294 ApoE4 Genotyping
868 KCNA2 antibodies (IgG)
557 Alzheimer's Disease Biomarkers – Extended Analysis
124 Infliximab
126 Adalimumab
128 Etanercept
130 Golimumab
132 Certolizumab
138 Vedolizumab
605 Ustekinumab
136 Natalizumab
613 Eculizumab
603 Rituximab
615 Abatacept
607 Tocilizumab
105 Erythropoietin
957 KLHL11 Antibodies (IgG)
558 Narcolepsy
540 Autoimmune Nodopathy/CIDP – Subclass Screen (IgG1-4)
883 Aquaporin 4 (AQP4) Antibodies (IgG) – Live CBA
885 MOG Antibodies (IgG) – Live CBA
561 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD – Live CBA
985 Glial Fibrillary Acidic Protein (GFAP)
200 Neuronal Antibody Screen – Tissue-Based Assay (TBA)
502 Autoantibodies in Dementia-Like Conditions
506 Inflammatory Neuropathy Screen– Extended Analysis

iLite
Complement
Calpro

Articles, Webinars & Downloads

Browse our comprehensive collection of posters, whitepapers, webinars, and downloadable resources for advanced scientific insights.

FILTER BY AREA

ALL Complement system Cell-Based Technology Svar CRO Services Gene Therapy

FILTER BY MATERIAL

ALL White Papers Posters Review Papers eBooks Interviews Videos & Webinars

Systematic Analysis of Fc Mutations Designed to Modulate Functional Activity

CELL-BASED TECHNOLOGY

Systematic Analysis of Fc Mutations Designed to Modulate Functional Activity

Therapeutic Antibodies Trimmed with GlycINATOR® Lose Antibody-Dependent Cell-mediated Cytotoxicity

CELL-BASED TECHNOLOGY

Therapeutic Antibodies Trimmed with GlycINATOR® Lose Antibody-Dependent Cell-mediated Cytotoxicity

Novel COVID-19 Biomarkers: The role of complement C4d

COMPLEMENT SYSTEM

Novel COVID-19 Biomarkers: The role of complement C4d

From Off-the-Shelf to Fit-for-Purpose: IVD-Compliant Biomarker Assay Optimization

SVAR CRO SERVICES

From Off-the-Shelf to Fit-for-Purpose: IVD-Compliant Biomarker Assay Optimization

Functional Detection of Neutralizing Antibodies Against Anti-Cancer Biotherapeutics

SVAR CRO SERVICES

Functional Detection of Neutralizing Antibodies Against Anti-Cancer Biotherapeutics

The Art of Partnership: Managing Expectations in Pharma-CRO Relationships

SVAR CRO SERVICES

The Art of Partnership: Managing Expectations in Pharma-CRO Relationships

Advancing Precision Medicine: Svar CRO Services + Olink® Technology

SVAR CRO SERVICES

Advancing Precision Medicine: Svar CRO Services + Olink® Technology

Tailored ADA Assay Solutions: Adapting to Long-Term Immunogenicity Challenges

SVAR CRO SERVICES

Tailored ADA Assay Solutions: Adapting to Long-Term Immunogenicity Challenges

Quantification of Bispecific Antibody Mediated T-cell Activation

CELL-BASED TECHNOLOGY

Quantification of Bispecific Antibody Mediated T-cell Activation

Complement System Specialist Review

COMPLEMENT SYSTEM

Complement System Specialist Review

Riding the Wave: the Complement Revolution in Neurodegeneration Research

COMPLEMENT SYSTEM

Riding the Wave: the Complement Revolution in Neurodegeneration Research

Unraveling Complement’s Role in Blindness: The Work of Professor Simon Clark

COMPLEMENT SYSTEM

Unraveling Complement’s Role in Blindness: The Work of Professor Simon Clark

Translating Research into Care - Exploring Complement with Dr Sophie Chauvet

COMPLEMENT SYSTEM

Translating Research into Care - Exploring Complement with Dr Sophie Chauvet

Insights on Targeting Complement Dysregulation - Dr. Elena Goicoechea de Jorge

COMPLEMENT SYSTEM

Insights on Targeting Complement Dysregulation - Dr. Elena Goicoechea de Jorge

IL-6 Biology, Inhibitors & COVID-19

CELL-BASED TECHNOLOGY

IL-6 Biology, Inhibitors & COVID-19

How to Perform a Wieslab® Complement System Screen

COMPLEMENT SYSTEM

How to Perform a Wieslab® Complement System Screen

Mechanism-linked Potency Assays Drive Gene Therapy Success

CELL-BASED TECHNOLOGY

Mechanism-linked Potency Assays Drive Gene Therapy Success

Addressing the Analytical Gaps in Modern Therapeutic Development

CELL-BASED TECHNOLOGY

Addressing the Analytical Gaps in Modern Therapeutic Development

20 Years of Innovation: The Legacy of the WIESLAB® Complement System Assays

COMPLEMENT SYSTEM

20 Years of Innovation: The Legacy of the WIESLAB® Complement System Assays

Developing a Customizable Complement-Dependent Cytotoxicity Assay

COMPLEMENT SYSTEM

Developing a Customizable Complement-Dependent Cytotoxicity Assay

Partnering for Progress: Supporting Alentis Therapeutics’ Mission

SVAR CRO SERVICES

Partnering for Progress: Supporting Alentis Therapeutics’ Mission

Meet the 2025 Svar Complement Excellence Award Recipients

COMPLEMENT SYSTEM

Meet the 2025 Svar Complement Excellence Award Recipients

Partnering for Success in a New Era of Advanced Therapeutics

CELL-BASED TECHNOLOGY

Partnering for Success in a New Era of Advanced Therapeutics

Integrating LC-MS and Ligand Binding Assays to Meet Bioanalytical Demands

SVAR CRO SERVICES

Integrating LC-MS and Ligand Binding Assays to Meet Bioanalytical Demands

Insights from Two Complement Excellence Award Recipients

COMPLEMENT SYSTEM

Insights from Two Complement Excellence Award Recipients

Functional Assessment of Properdin or AP-Modulation?

COMPLEMENT SYSTEM

Functional Assessment of Properdin or AP-Modulation?

Unlocking the Power of C1q in Autoimmune Disease and Therapeutic Innovation

COMPLEMENT SYSTEM

Unlocking the Power of C1q in Autoimmune Disease and Therapeutic Innovation

The Importance of Investigating Complement System in Gene Therapy

COMPLEMENT SYSTEM

The Importance of Investigating Complement System in Gene Therapy

Get a Free Complement System Poster

COMPLEMENT SYSTEM

Get a Free Complement System Poster

The Immune Response to AAV Gene Therapy

CELL-BASED TECHNOLOGY

The Immune Response to AAV Gene Therapy

Design of Biosimilar Bioanalytical Programs: PK Assay Considerations

SVAR CRO SERVICES

Design of Biosimilar Bioanalytical Programs: PK Assay Considerations

How to Design Potency Assays for Gene Therapy Projects

SVAR CRO SERVICES

How to Design Potency Assays for Gene Therapy Projects

A Cell-Based ADCC Bioassay Comparison

SVAR CRO SERVICES

A Cell-Based ADCC Bioassay Comparison

Validation of the Wieslab® Complement System Screen Assay

COMPLEMENT SYSTEM

Validation of the Wieslab® Complement System Screen Assay

Quantification of the Neutralizing Antibody Response to Recombinant AAV Vectors

CELL-BASED TECHNOLOGY

Quantification of the Neutralizing Antibody Response to Recombinant AAV Vectors

Svar Complement Assays: Analyzing How Drug Candidates Affect the Complement System

SVAR CRO SERVICES

Svar Complement Assays: Analyzing How Drug Candidates Affect the Complement System

Complement Components as Prognostic Biomarkers in Renal Cancer

COMPLEMENT SYSTEM

Complement Components as Prognostic Biomarkers in Renal Cancer

Assay Development in AAV Therapies: Engineering iLite® Cell Lines for Specific and Analytical Applications

CELL-BASED TECHNOLOGY

Assay Development in AAV Therapies: Engineering iLite^® Cell Lines for Specific and Analytical Applications

Measuring C5a With a Functional Bioassay

CELL-BASED TECHNOLOGY

Measuring C5a With a Functional Bioassay

Establishment of a Novel iLite® Reporter Gene Assay Response to Insulin Products

CELL-BASED TECHNOLOGY

Establishment of a Novel iLite^® Reporter Gene Assay Response to Insulin Products

Evaluation of iLite® ADCC Effector Cells Using Different CD20 Target Cells

CELL-BASED TECHNOLOGY

Evaluation of iLite^® ADCC Effector Cells Using Different CD20 Target Cells

Development of an FGF21 iLite® Reporter Gene Cell Line

CELL-BASED TECHNOLOGY

Development of an FGF21 iLite^® Reporter Gene Cell Line

Quantification of ADCC Activity of Therapeutic Antibodies & Tolerance to Human Serum

CELL-BASED TECHNOLOGY

Quantification of ADCC Activity of Therapeutic Antibodies & Tolerance to Human Serum

Designing Optimal Bioassays for Measuring ADCC & ADCP Activity

CELL-BASED TECHNOLOGY

Designing Optimal Bioassays for Measuring ADCC & ADCP Activity

Fast and Efficient Evaluation of the Impact of Fc N-glycosylation on ADCC

CELL-BASED TECHNOLOGY

Fast and Efficient Evaluation of the Impact of Fc N-glycosylation on ADCC

Roundtable: Challenges & Solutions in Next-Gen Complement Therapeutics

COMPLEMENT SYSTEM

Roundtable: Challenges & Solutions in Next-Gen Complement Therapeutics

Unravelling the Mysteries of Complement Activation in the Lung

COMPLEMENT SYSTEM

Unravelling the Mysteries of Complement Activation in the Lung

Outline for Characterization of Reporter Cell Lines

CELL-BASED TECHNOLOGY

Outline for Characterization of Reporter Cell Lines

Quantification of ADCP Activity of Therapeutic Antibodies Using Engineered Effector Cells and Target Cells

CELL-BASED TECHNOLOGY

Quantification of ADCP Activity of Therapeutic Antibodies Using Engineered Effector Cells and Target Cells

Developing a Highly Sensitive, MoA-Reflecting ADCC iLite® Reporter Gene Assay

CELL-BASED TECHNOLOGY

Developing a Highly Sensitive, MoA-Reflecting ADCC iLite^® Reporter Gene Assay

Advancing Monoclonal Antibodies Development with iLite® CDC Bioassays

COMPLEMENT SYSTEM

Advancing Monoclonal Antibodies Development with iLite^® CDC Bioassays

Factors Affecting the Immunogenicity of Biopharmaceuticals

SVAR CRO SERVICES

Factors Affecting the Immunogenicity of Biopharmaceuticals

An iLite® Reporter Cell Platform to Quantify Anti-AAV Neutralizing Antibodies

CELL-BASED TECHNOLOGY

An iLite^® Reporter Cell Platform to Quantify Anti-AAV Neutralizing Antibodies

Bispecific Antibodies – Quantifying Their Activity Using iLite® Bioassays

CELL-BASED TECHNOLOGY

Bispecific Antibodies – Quantifying Their Activity Using iLite^® Bioassays

A Novel Method for ADCC Activity Quantification using Engineered Effector Cells

CELL-BASED TECHNOLOGY

A Novel Method for ADCC Activity Quantification using Engineered Effector Cells

Functional Assays for Biopharmaceutical Development Success

SVAR CRO SERVICES

Functional Assays for Biopharmaceutical Development Success

iLite® Cell-Based Assays – An hCG Case Study

CELL-BASED TECHNOLOGY

iLite^® Cell-Based Assays – An hCG Case Study

The Complement System Provides Promise of Novel Prognostic Biomarkers for Cancer

COMPLEMENT SYSTEM

The Complement System Provides Promise of Novel Prognostic Biomarkers for Cancer

Navigating the Complexities of Cell-based Assays in GMP QC Testing: The Journey to Robust Assays

SVAR CRO SERVICES

Navigating the Complexities of Cell-based Assays in GMP QC Testing: The Journey to Robust Assays

Cell-based Assays in Immuno-oncology: Advancing Bispecific Antibody Development

CELL-BASED TECHNOLOGY

Cell-based Assays in Immuno-oncology: Advancing Bispecific Antibody Development

The Value of Assay-Ready Cells in Providing Biologically Relevant Data for Robust Therapeutic Development

CELL-BASED TECHNOLOGY

The Value of Assay-Ready Cells in Providing Biologically Relevant Data for Robust Therapeutic Development

Behind the Scenes at Novartis: The Development of Robust Cell-Based Assays for Gene Therapy

SVAR CRO SERVICES

Behind the Scenes at Novartis: The Development of Robust Cell-Based Assays for Gene Therapy

How Biosimilars Are Expanding Options for Patient Care

SVAR CRO SERVICES

How Biosimilars Are Expanding Options for Patient Care

Biosimilar Development: Experts Discuss Analytical Characterization Toolkits for Antibody Therapeutics

CELL-BASED TECHNOLOGY

Biosimilar Development: Experts Discuss Analytical Characterization Toolkits for Antibody Therapeutics

The Future of Drug Development for Complex Pathologies: Versatile Cell-based Assays and Customizable Cell Lines

SVAR CRO SERVICES

The Future of Drug Development for Complex Pathologies: Versatile Cell-based Assays and Customizable Cell Lines

Complement in Drug Discovery: The Key to Addressing a Large Unmet Therapeutic Need

SVAR CRO SERVICES

Complement in Drug Discovery: The Key to Addressing a Large Unmet Therapeutic Need

Researchers Develop a Promising New Therapy to Tackle Metabolic Liver Disease, NASH

CELL-BASED TECHNOLOGY

Researchers Develop a Promising New Therapy to Tackle Metabolic Liver Disease, NASH

The Complement System in Infectious Disease: Expert Opinion on Future Diagnostic and Therapeutic Potentials

COMPLEMENT SYSTEM

The Complement System in Infectious Disease: Expert Opinion on Future Diagnostic and Therapeutic Potentials

New Complement Pathway Insights and Designing Artificial Complement Regulators

COMPLEMENT SYSTEM

New Complement Pathway Insights and Designing Artificial Complement Regulators

Paving the Way for Novel Complement Components Roles and New Therapeutic Modulation Opportunities

COMPLEMENT SYSTEM

Paving the Way for Novel Complement Components Roles and New Therapeutic Modulation Opportunities

Exploring Existing Human Complement C4d, TCC & Functional Activity Assays

COMPLEMENT SYSTEM

Exploring Existing Human Complement C4d, TCC & Functional Activity Assays

Harnessing the Power of Cyclic Peptides: A Journey into Complement System Modulation

COMPLEMENT SYSTEM

Harnessing the Power of Cyclic Peptides: A Journey into Complement System Modulation

Unlock Insights in AAV Gene Therapy Development with our Latest Scientific Posters

COMPLEMENT SYSTEM

Unlock Insights in AAV Gene Therapy Development with our Latest Scientific Posters

Webinar - Advancements in GMP QC Testing: A Comprehensive Guide to Cell-Based Assays

SVAR CRO SERVICES

Webinar - Advancements in GMP QC Testing: A Comprehensive Guide to Cell-Based Assays

Webinar - AAV Safety and Potency: Exploring the Analytical Maze of Gene Therapy

COMPLEMENT SYSTEM

Webinar - AAV Safety and Potency: Exploring the Analytical Maze of Gene Therapy

Ensuring Quality and Adaptability when Assessing Neutralizing Antibodies in AAV-Mediated Gene Therapy

CELL-BASED TECHNOLOGY

Ensuring Quality and Adaptability when Assessing Neutralizing Antibodies in AAV-Mediated Gene Therapy

A Guide to Complement Therapeutics for Drug Development Professionals

COMPLEMENT SYSTEM

A Guide to Complement Therapeutics for Drug Development Professionals

Functional Bioassays Measuring the Potency of Complement Therapeutics

COMPLEMENT SYSTEM

Functional Bioassays Measuring the Potency of Complement Therapeutics

Development of an iLite® Reporter Cell Platform for the Quantification of Anti-AAV Neutralizing Antibodies

CELL-BASED TECHNOLOGY

Development of an iLite^® Reporter Cell Platform for the Quantification of Anti-AAV Neutralizing Antibodies

Developing a Reporter Gene Cell Line for Easy Assessment of Therapeutic AAV Vectors

CELL-BASED TECHNOLOGY

Developing a Reporter Gene Cell Line for Easy Assessment of Therapeutic AAV Vectors

Advanced Assay Platform for Antibody Development: Precision Assays for ADCC, ADCP, and CDC

COMPLEMENT SYSTEM

Advanced Assay Platform for Antibody Development: Precision Assays for ADCC, ADCP, and CDC

Unveiling the Dynamics of Complement Activation in Dialysis: Insights from Invizius

COMPLEMENT SYSTEM

Unveiling the Dynamics of Complement Activation in Dialysis: Insights from Invizius

SVAR LIFE SCIENCE

Contact Form Contact Form
Phone +46 40 53 76 00
Address P.O. Box 50117
SE-202 11, Malmö
Sweden
Visiting Address Lundavägen 151
SE-212 25, Malmö
Sweden

SVAR LIFE SCIENCE INC

Email sales.us@svarlifescience.com
Address 105 State Route 101A, Unit 12
Amherst, NH 03031
USA

WIESLAB

Contact Form Contact Form
Phone +46 40 53 76 60 (lab)
+46 40 53 76 70 (invoices)
Address P.O. Box 50117
SE-202 11, Malmö
Sweden
Visiting Address Lundavägen 151
SE-212 25, Malmö
Sweden

IMPORTANT LINKS

Privacy and Cookies Cookie Information
Cookie settings
Privacy Policy
Data Protection Officer (DPO)
Terms & Conditions Terms & Conditions – Svar
Terms & Conditions – Wieslab
Sustainability Find out how we help
Copyright Copyright